ConductScience.org, home

Paper32100595

LncRNA PEAMIR inhibits apoptosis and inflammatory response in PM2.5 exposure aggravated myocardial ischemia/reperfusion injury as a competing endogenous RNA of miR-29b-3p.

Pei YH and 11 others. Nanotoxicology, 2020. Cited by 56 papers, by iCite.

Cite this record

ConductScience Library. LncRNA PEAMIR inhibits apoptosis and inflammatory response in PM2.5 exposure aggravated myocardial ischemia/reperfusion injury as a competing endogenous RNA of miR-29b-3p. Papers, record 32100595. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32100595

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
LncRNA PEAMIR inhibits apoptosis and inflammatory response in PM2.5 exposure aggravated myocardial ischemia/reperfusion injury as a competing endogenous RNA of miR-29b-3p.
PubMed
Journal
Nanotoxicology
PubMed
Year
2020
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
56
iCite
Relative citation ratio, by iCite
3.28
iCite
Revised in PubMed
2020-08-31
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pei YHYing-Hao
2Chen JJie
3Wu XXiang
4He YYun
5Qin WWei
6He SYShu-Yin
7Chang NNing
8Jiang HHua
9Zhou JJiang
10Yu PPeng
11Shi HBHai-Bo
12Chen XHXiao-Hu

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ApoptosisMajor topic
MicroRNAsMajor topic
Myocardial Reperfusion InjuryMajor topic
MyocardiumMajor topic
Particulate MatterMajor topic
RNA, Long NoncodingMajor topic
Animals
Cell Line
Disease Models, Animal
Down-Regulation
Gene Expression
Inflammation
Myocytes, Cardiac
Particle Size
RNA
Rats
Up-Regulation

Source PubMed

Download CSV of topics

Cited by33

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 56 citations.

PMIDTitleJournalYearIn PapersSource
41992981ETS‑1/ETS‑2 transcription factors in CVD (Review).Int J Mol Med2026https://conductscience.org/library/papers/41992981PubMed
39997913Transcriptome-Wide Analysis of N6-Methyladenosine-Modified Long Noncoding RNAs in Particulate Matter-Induced Lung Injury.Toxics2025https://conductscience.org/library/papers/39997913PubMed
39888395From smog to scarred hearts: unmasking the detrimental impact of air pollution on myocardial ischemia-reperfusion injury.Cell Mol Life Sci2025https://conductscience.org/library/papers/39888395PubMed
39296207Time of day-dependent alterations of ferroptosis in LPS-induced myocardial injury via Bmal-1/AKT/ Nrf2 in rat and H9c2 cell.Heliyon2024https://conductscience.org/library/papers/39296207PubMed
39245438Mir221- and Mir222-enriched adsc-exosomes mitigate PM exposure-exacerbated cardiac ischemia-reperfusion injury through the modulation of the BNIP3-MAP1LC3B-BBC3/PUMA pathway.Autophagy2025https://conductscience.org/library/papers/39245438PubMed
38912363Scutellarin Protects against Myocardial Ischemia-reperfusion Injury by Enhancing Aerobic Glycolysis through miR-34c-5p/ALDOA Axis.Int J Appl Basic Med Res2024https://conductscience.org/library/papers/38912363PubMed
38234046LncRNA SNHG1 alleviates myocardial ischaemia-reperfusion injury by regulating the miR-137-3p/KLF4/TRPV1 axis.ESC Heart Fail2024https://conductscience.org/library/papers/38234046PubMed
38172743Mechanisms by which silencing long-stranded noncoding RNA KCNQ1OT1 alleviates myocardial ischemia/reperfusion injury (MI/RI)-induced cardiac injury via miR-377-3p/HMOX1.BMC Cardiovasc Disord2024https://conductscience.org/library/papers/38172743PubMed
37878166MicroRNA-specific therapeutic targets and biomarkers of apoptosis following myocardial ischemia-reperfusion injury.Mol Cell Biochem2024https://conductscience.org/library/papers/37878166PubMed
37720410Downregulation of MicroRNA-29-3p Following Percutaneous Coronary Intervention: An Implication of YY1/IRAK1 Pathway in the Post-Vascular Injury Inflammation.Acta Cardiol Sin2023https://conductscience.org/library/papers/37720410PubMed
37389674The Role of P53 in Myocardial Ischemia-Reperfusion Injury.Cardiovasc Drugs Ther2025https://conductscience.org/library/papers/37389674PubMed
37046145LPS-aggravated Ferroptosis via Disrupting Circadian Rhythm by Bmal1/AKT/p53 in Sepsis-Induced Myocardial Injury.Inflammation2023https://conductscience.org/library/papers/37046145PubMed
36923213Integrated analysis of long non-coding RNAs and mRNAs associated with glaucoma in vitro.Front Endocrinol (Lausanne)2023https://conductscience.org/library/papers/36923213PubMed
36545243Long Noncoding RNA SNHG4 Attenuates the Injury of Myocardial Infarction via Regulating miR-148b-3p/DUSP1 Axis.Cardiovasc Ther2022https://conductscience.org/library/papers/36545243PubMed
36447278A comprehensive understanding of ambient particulate matter and its components on the adverse health effects based from epidemiological and laboratory evidence.Part Fibre Toxicol2022https://conductscience.org/library/papers/36447278PubMed
36301033MicroRNA-582-5p targeting Creb1 modulates apoptosis in cardiomyocytes hypoxia/reperfusion-induced injury.Immun Inflamm Dis2022https://conductscience.org/library/papers/36301033PubMed
36225178The Effect of miR-505-5p on Inhibition of Serum Uromodulin Ameliorates Myocardial Inflammation and Apoptosis Induced by Ischemia-Reperfusion.Oxid Med Cell Longev2022https://conductscience.org/library/papers/36225178PubMed
36210816MicroRNAs: Potential mediators between particulate matter 2.5 and Th17/Treg immune disorder in primary membranous nephropathy.Front Pharmacol2022https://conductscience.org/library/papers/36210816PubMed
36189147Integrated Bioinformatics and Validation of lncRNA-Mediated ceRNA Network in Myocardial Ischemia/Reperfusion Injury.J Immunol Res2022https://conductscience.org/library/papers/36189147PubMed
36034861Artemisinin relieves myocardial ischemia-reperfusion injury via modulating miR-29b-3p and hemicentin 1.Front Pharmacol2022https://conductscience.org/library/papers/36034861PubMed

See all 33 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32100595

GET https://conductscience.org/api/papers/v1/32100595/cited_by?page=2